Associated Papers
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general population.
Martinez Rodriguez A et al.
British Journal of Haematology, 2026
Clinical Manifestations of VEXAS Syndrome Across a Broad Spectrum of UBA1 Mutation Burden.
Anderson M et al.
Arthritis & Rheumatology (hoboken, N.j.), 2026
Rapid clinical deployment of UBA1 testing in patients with VEXAS syndrome.
Wadsworth PA et al.
American Journal of Clinical Pathology, 2025
Clonal hematopoiesis meets an autoinflammatory disease: the new paradigm of VEXAS syndrome.
Fiumara M et al.
Expert Review of Hematology, 2025
VEXAS syndrome: A newly identified X-Linked hematoinflammatory disorder - A comprehensive overview of its genetic, molecular, inflammatory, and clinical landscape.
Singh A et al.
Journal of Autoimmunity, 2025
Role of allogeneic hematopoietic cell transplantation in VEXAS syndrome.
Dias AL et al.
Annals of Hematology, 2024
VEXAS without vacuoles: Linking genotype to phenotype.
Zhukovsky S et al.
Ejhaem, 2024
How I diagnose and manage VEXAS syndrome.
Hagiya A et al.
American Journal of Clinical Pathology, 2024
Shared and distinct mechanisms of UBA1 inactivation across different diseases.
Collins JC et al.
The Embo Journal, 2024
VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management.
Koster MJ et al.
American Journal of Hematology, 2024
VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
Loeza-Uribe MP et al.
Reumatologia Clinica, 2024
Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases.
Collins JC et al.
Biorxiv : the Preprint Server for Biology, 2023
An update on VEXAS syndrome.
Al-Hakim A et al.
Expert Review of Clinical Immunology, 2023
Select a paper to view details